Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2021-10-28 Regulatory Filings
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT ANTI-COUNTERFEITING FOR TEA LEAVES INDUSTRY BUSINESS UPDATE
Regulatory Filings Classification · 90% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding a business update on their anti-counterfeiting products in the tea leaves industry. It does not contain financial statements, earnings data, or regulatory filings such as annual or interim reports. The content focuses on business development and market expansion rather than financial results or governance changes. The document is longer than 5,000 characters and provides substantive business information, but it is not a formal financial report or regulatory filing. It is an update on business activities, which fits best under the category of a Capital/Financing Update (CAP) or a general business update. However, since it does not mention fundraising or capital structure changes explicitly, and is more about business development, the best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories specifically. Therefore, the classification is RNS with high confidence.
2021-10-28 English
VOLUNTARY ANNOUNCEMENT UPDATE ON ANTI-COUNTERFEITING BUSINESS PROGRESS
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding the progress of its anti-counterfeiting business, specifically a new commercial contract and business development update. It does not contain financial statements, regulatory certifications, voting results, or detailed financial data. The document is relatively short (5274 characters) and serves to inform shareholders and investors about business progress rather than presenting a formal report or financial results. It is not an Annual Report, Interim Report, Earnings Release, or any other formal financial filing. It is also not related to board changes, legal proceedings, or capital changes. The content fits best as a general regulatory announcement updating the market on business developments. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-10-27 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change Classification · 95% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and/or share buybacks for Sinopharm Tech Holdings Limited. It details the allotment and issue of Loan Capitalisation Shares, including the number of shares issued, issue price, and percentage changes in issued shares. The document includes confirmations by the company secretary regarding authorization and compliance with listing rules. The content focuses on share capital changes and share issuance details, which aligns with announcements regarding share issues or capital changes. The document is not a full financial report, audit, or management discussion, nor is it a voting result or AGM material. It is a regulatory disclosure specific to share capital changes, fitting the category of Share Issue/Capital Change (SHA). The document length (7538 characters) and detailed data support it being a substantive announcement rather than a brief notice or certification, reinforcing the SHA classification.
2021-10-20 English
FORM OF PROXY
AGM Information Classification · 95% confidence The document is a Form of Proxy for use by shareholders at the Annual General Meeting (AGM) of Sinopharm Tech Holdings Limited. It includes instructions for appointing a proxy to vote on various resolutions at the AGM, such as receiving the audited financial statements, re-electing directors, appointing auditors, and granting mandates to the board. The document does not contain the actual financial statements or detailed reports but is a procedural document related to the AGM. Therefore, it is classified as AGM Information (AGM-R). The document length is 5943 characters, which is consistent with a proxy form rather than a full report.
2021-10-20 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Sinopharm Tech Holdings Limited related to the Annual General Meeting (AGM). It includes proposals for general mandates to issue and repurchase shares, re-election of retiring directors, and the notice of the AGM. It contains detailed information about the resolutions to be proposed at the AGM, proxy forms, and explanatory statements. The document is not a presentation, transcript, or financial report but rather a formal circular providing information and notice for the AGM. This fits the definition of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or a brief notice, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is PSI with high confidence.
2021-10-20 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and details the agenda for the AGM of Sinopharm Tech Holdings Limited, including resolutions to receive the annual audited financial statements, re-election of directors, appointment of auditors, and share issuance and repurchase authorities. It is a formal notice announcing the date, time, and location of the AGM and the business to be conducted. The document does not contain the actual annual report or financial statements but rather the notice for the meeting where these will be discussed and approved. The length is about 10,688 characters, which is consistent with a detailed notice but not a full report. Therefore, this document is best classified as AGM Information (AGM-R).
2021-10-20 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.